BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30145563)

  • 1. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
    Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
    Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes.
    Barton JC; Chen WP; Emond MJ; Phatak PD; Subramaniam VN; Adams PC; Gurrin LC; Anderson GJ; Ramm GA; Powell LW; Allen KJ; Phillips JD; Parker CJ; McLaren GD; McLaren CE
    Blood Cells Mol Dis; 2017 Mar; 63():15-20. PubMed ID: 27936396
    [TBL] [Abstract][Full Text] [Related]  

  • 3.  GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
    Levstik A; Stuart A; Adams PC
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors.
    Greni F; Valenti L; Mariani R; Pelloni I; Rametta R; Busti F; Ravasi G; Girelli D; Fargion S; Galimberti S; Piperno A; Pelucchi S
    Ann Hepatol; 2017; 16(3):451-456. PubMed ID: 28425416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes.
    Barton JC; Barton JC; Adams PC
    Ann Hepatol; 2019; 18(2):354-359. PubMed ID: 31056361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.
    Barton JC; Barton JC; Acton RT
    BMC Gastroenterol; 2023 Apr; 23(1):137. PubMed ID: 37118679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload.
    McLaren CE; Emond MJ; Subramaniam VN; Phatak PD; Barton JC; Adams PC; Goh JB; McDonald CJ; Powell LW; Gurrin LC; Allen KJ; Nickerson DA; Louie T; Ramm GA; Anderson GJ; McLaren GD
    Hepatology; 2015 Aug; 62(2):429-39. PubMed ID: 25605615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels.
    Secondes ES; Wallace DF; Rishi G; McLaren GD; McLaren CE; Chen WP; Ramm LE; Powell LW; Ramm GA; Barton JC; Subramaniam VN
    Blood Cells Mol Dis; 2020 Nov; 85():102463. PubMed ID: 32652459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS Study.
    Barton JC; Barton JC; Adams PC; Acton RT
    Metab Syndr Relat Disord; 2016 Mar; 14(2):94-101. PubMed ID: 26771691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
    World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
    McLaren GD; McLaren CE; Adams PC; Barton JC; Reboussin DM; Gordeuk VR; Acton RT; Harris EL; Speechley MR; Sholinsky P; Dawkins FW; Snively BM; Vogt TM; Eckfeldt JH;
    Can J Gastroenterol; 2008 Nov; 22(11):923-30. PubMed ID: 19018338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.
    Barton JC; Barton JC; Patel N; McLaren GD
    PLoS One; 2021; 16(12):e0261690. PubMed ID: 34932603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
    Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
    Pilling LC; Atkins JL; Melzer D
    Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y.
    Barton JC; Barton JC; Acton RT
    PLoS One; 2022; 17(7):e0271973. PubMed ID: 35895739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet counts in
    Barton JC; Barton JC; Acton RT
    Platelets; 2023 Dec; 34(1):2217933. PubMed ID: 37260121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.